BIO

Physician, scientist, innovator, academic teacher at the Medical University of Warsaw, accomplished specialization in hematology at the Department of Hematology, Transplantation and Internal Medicine University Clinical Center of Medical University of Warsaw. Founder and CEO of Human Biome S.A. – innovative R&D company working on biosynthetic microbiome and microbiome-based drugs, being his research commercialization. Former vice president of the Regional Medical Council in Warsaw.

During his medical studies, he was a laureate of many competitions and a Scholarship of the Minister of Science and Higher Education. In 2013 he graduated from the Faculty of Medicine with the highest score of the year at the Collegium Medicum in Bydgoszcz of the Nicolaus Copernicus University in Toruń. He graduated, a year before the plan, of doctoral studies at the Medical University of Warsaw and in 2017 he defended his doctoral dissertation with distinction at the First Medical Faculty of the Medical University of Warsaw and habilitation in 2024. Laureate (5th place) in Supertalents in Medicine 2025. Winner of the prestigious Award of the 5th Faculty of Medicine of the Polish Academy of Sciences. In 2020, he was the winner in the prestigious polish “Golden OTIS” competition in the “scientific debut of the year” category. Also, in 2020, elected as an “Young Ambassador” of the European Society for Blood and Marrow Transplantation (EBMT). In 2025, awarded the Medal of J. Moskwa by the District Medical Chamber in Warsaw.

In his research work, he deals with topics in the fields of microbiome, hematology, clinical transplantology, immunology, metagenomics, genetics and cancer response, interactions of the human microbiome with the host and longevity, healthy-ageing. Author of many full-text publications in prestigious scientific journals, conference summaries and conference reports, including at prestigious international congresses. Impact Factor> 200, Hirsch index 15, Number of citations> 1000. Leader of 7 research grants (over 3 million euro in total), co-researcher in the international clinical trials, including study within the framework of the European Society for Blood and Marrow Transplantation (EBMT). Currently fully focused on Human Biome S.A. development and providing the first human biosynthetic microbiome and derived medicines, alongside with his scientific research.